ArticleAnnals of translational medicine2019

Cardiovascular and renal protection with sodium-glucose cotransporter type 2 inhibitors: new paradigm in type 2 diabetes management…and potentially beyond.

André J ScheenPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.